The Arrhythmic Mitral Valve Prolapse Syndrome: A New Insight for Understanding the Arrhythmogenic Substrate?
- PMID: 40447364
- PMCID: PMC12235458
- DOI: 10.1016/j.jaccas.2025.103419
The Arrhythmic Mitral Valve Prolapse Syndrome: A New Insight for Understanding the Arrhythmogenic Substrate?
Abstract
Background: Mitral valve prolapse (MVP) is the most common valvular heart disease and historically was considered benign in the absence of severe mitral regurgitation and normal left ventricular function. However, an emerging subset associated with sudden cardiac death that does not follow traditional risk stratification has been established termed the arrhythmic mitral valve prolapse (A-MVP) syndrome. This cohort provide a clinical challenge on identifying those at risk of lethal arrhythmias who may benefit from a primary prevention implantable cardiac defibrillator.
Case summary: We present 7 cases in which patients have survived cardiac arrest due to A-MVP, with the aim of further describing phenotypic characteristics that define this syndrome.
Discussion: We observed that after arrest, a high proportion of patients developed rapidly worsening mitral regurgitation. This observed link may provide insight into the underlying substrate of arrhythmogenesis.
Keywords: cardiac magnetic resonance; cardiac risk; echocardiography; electrophysiology; mitral valve; phenotype; primary prevention; ventricular fibrillation; ventricular tachycardia.
Crown Copyright © 2025. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
-
- Sabbag A., Essayagh B., Barrera J., et al. EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed by the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society. EP Europace. 2022;24(12):1981–2003. doi: 10.1093/europace/euac125. - DOI - PMC - PubMed
-
- Otto C., Nishimura R., Bonow R., et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;143(5):e35–e71. doi: 10.1161/CIR.0000000000000923. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
